NovoCure (NVCR) Accumulated Expenses (2014 - 2018)

NovoCure has disclosed Accumulated Expenses across 5 years of filings, most recently posting $16.7 million for Q4 2018.

• Accumulated Expenses for Q4 2018 came in at $16.7 million, up 25.85% year-over-year; the trailing twelve-month figure through Dec 2018 was $16.7 million (up 25.85% YoY), and the FY2018 annual result was $16.7 million, up 25.85% from the prior year.
• Accumulated Expenses came in at $16.7 million for Q4 2018 at NovoCure, up from $13.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $16.7 million in Q4 2018 to a low of $5.8 million in Q4 2014.
• The 5-year median for Accumulated Expenses is $8.3 million (2015), against an average of $10.3 million.
• Across the five-year window, Accumulated Expenses dropped 8.68% in 2016 and soared 76.14% in 2017, its largest moves.
• NovoCure's Accumulated Expenses stood at $5.8 million in 2014, then soared by 41.26% to $8.3 million in 2015, then decreased by 8.68% to $7.5 million in 2016, then jumped by 76.14% to $13.3 million in 2017, then climbed by 25.85% to $16.7 million in 2018.
• The last three Accumulated Expenses figures came in at $16.7 million (Q4 2018), $13.3 million (Q4 2017), and $7.5 million (Q4 2016), per Business Quant data.